Impaired Fasting Glucose & 8-Iso-Prostaglandin F2α in Diabetes Disease Progression

References (47)

1. 1 Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge [DOI]
2. 2 Free Radicals in the Physiological Control of Cell Function [DOI]
3. 3 Oxidative Stress and Diabetic Complications [DOI]
4. 4 The Pathobiology of Diabetic Complications [DOI]
5. 5 C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus [DOI]
6. 6 Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain [DOI]
7. 7 Redefining Oxidative Stress [DOI]
8. 8 Diabetes research and clinical practice [DOI]
9. 9 Protein Oxidation [DOI]
10. 10 Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice [DOI]
11. 11 Measurement of F2-isoprostanes as an index of oxidative stress in vivo [DOI]
12. 12 Oxidative Stress and Cell Signalling [DOI]
13. 13 Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor [DOI]
14. 14 The Role of Oxidative Stress in Diabetic Complications [DOI]
15. 15 The Loss of Postprandial Glycemic Control Precedes Stepwise Deterioration of Fasting With Worsening Diabetes [DOI]
16. 16 Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans [DOI]
17. 17 Oxidative and nitrosative stress in acute renal ischemia [DOI]
18. 18 The distribution of 10-Year risk for coronary heart disease among U.S. adults [DOI]
19. 19 Prostaglandins, Leukotrienes and Essential Fatty Acids
20. 20 Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes [DOI]
21. 21 Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus [DOI]
22. 22 Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat [DOI]
23. 23 Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia [DOI]
24. 24 Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and β-cell failure? [DOI]
25. 25 Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus [DOI]
26. 26 Association Between Lipid Profile and Risk of Atrial Fibrillation - Niigata Preventive Medicine Study - [DOI]
27. 27 HDL is the major lipoprotein carrier of plasma F2-isoprostanes [DOI]
28. 28 Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol? [DOI]
29. 29 Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease [DOI]
30. 30 Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism [DOI]
31. 31 Glucose “peak” and glucose “spike”: Impact on endothelial function and oxidative stress [DOI]
32. 32 Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites [DOI]
33. 33 Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus [DOI]
34. 34 Epidemiology of Prediabetes [DOI]
35. 35 Plasma Free Fatty Acids and Risk of Atrial Fibrillation (from the Cardiovascular Health Study) [DOI]
36. 36 Mechanisms of Vascular Complications in Prediabetes [DOI]
37. 37 Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes [DOI]
38. 38 Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes [DOI]
39. 39 Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus [DOI]
40. 40 MEASUREMENT OF F2-ISOPROSTANES AS AN INDEX OF OXIDATIVE STRESS IN VIVO [DOI]
41. 41 Assessment of diabetic macrovascular complications: a prediabetes model [DOI]
42. 42 Comparison of Oxidant/Antioxidant, Detoxification Systems in Various Tissue Homogenates and Mitochondria of Rats with Diabetes Induced by Streptozocin [DOI]
43. 43 Epidemiology of Prediabetes [DOI]
44. 44 The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F 2a levels [DOI]
45. 45 Isoprostanes, a marker of lipid peroxidation, may not be involved in the development of glucose intolerance [DOI]
46. 46 Is F2-isoprostane a biological marker for the early onset of type 2 diabetes mellitus? [DOI]
47. 47 Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol? [DOI]

Cited by 13

Showing 5 of 13 known citations — external sources report more than can currently be individually listed.

Related research

• Salivary Lipid Peroxidation and Antioxidant Status in Nigerian Cigarette Smokers with or Without Periodontitis — shares topic coverage
• Profile of Biochemical and Oxidative Stress Markers in Male Athletes Following Strenuous Exercise Session — shares topic coverage
• Atherogenicity, Oxidative Stress, Heavy Metals and Bioelements Status in Hypertensive Nigerians in an Urban Population — shares topic coverage
• Oxidative Stress Biomarkers (Malondialdehyde, Superoxide Dismutase, and Catalase) as Predictors of Cardiovascular Disease Risk: A Review — shares topic coverage
• Ebselen a Seleno-organic Molecule Inhibits Alteration in the Biological Responses in Hypoxic Human Alveolar Lung Epithelial Cells — shares topic coverage